Granules India Ltd. (GRANULES) Share Price Rise Streak: second straight session at Rs 831.55

SUMMARY Granules India Ltd. Share Price Rise Streak is in its second straight session, with the latest traded price at Rs 831.55, up 2.29%, and market capitalisation at Rs 22,039.25 Cr.

Granules India Ltd. Share Price Rise Streak is trading higher in its second straight session, with the cumulative move across the streak at 2.92% from the Rs 807.95 base. The latest traded price is Rs 831.55, and according to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers following Granules India Ltd. Share Price, the important point is the pattern of consecutive higher sessions rather than a single move in isolation.

Granules India Ltd. Share Price Rise Streak: Consecutive Gain Analysis

Granules India Ltd. Share Price Rise Streak matters because the stock is now being read through a short run of higher sessions while its market capitalisation stands at Rs 22,039.25 Cr. A second straight session can draw attention even when the broad reason is unconfirmed, because it helps frame Granules India Ltd. Share Price against the prior day’s base and against sector peers. According to latest Univest data, the move is visible in price action first, while the deeper context comes from valuation, sector benchmarks and listed comparables.

Granules India Ltd. (GRANULES) rose to Rs 831.55 from the previous close of Rs 812.95, a move of Rs 18.6 or 2.29%. The stock opened at Rs 814.15, reached a high of Rs 833.35, recorded a low of Rs 801.95.

Granules India Ltd. Share Price Today shows a steady intraday rise in the second straight session, with the latest traded price at Rs 831.55 versus the previous close of Rs 812.95. The stock was up Rs 18.60, or 2.29%, and moved within a range of Rs 801.95 to Rs 833.35 after opening at Rs 814.15. The price sat near the upper end of that range as it approached the day’s high.

For Granules India Ltd. Share Price, the session matters because the move is not a one-line headline on its own; it is part of a two-session pattern that has taken the stock from Rs 807.95 to the latest trade. That means the market has now seen back-to-back higher sessions, with the current level also placing the stock close to the session high. Market capitalisation at Rs 22,039.25 Cr keeps the move relevant for readers tracking Granules India Ltd. Share Price Today, Granules India Ltd. Share Price Live and Granules India Ltd. Stock Performance. The next section shifts from price action to Granules India Ltd. Fundamental Analysis and valuation context.

What the Consecutive Gains Show

Seen on its own, the latest session still remains the sharper intraday signal, but the streak adds a broader frame for Granules India Ltd. Stock Gaining Today and Granules India Ltd. Share Price Update tracking. According to Univest data, the pattern is confirmed, while no company-specific catalyst is established. That makes the streak useful as a price-development note rather than a causal story. For readers following Granules India Ltd. Share News and Granules India Ltd. Latest News, the focus stays on the verified numbers and how the run compares with sector benchmarks later in the article.

Granules India Ltd. (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 22,039.25 crore
P/E Ratio	33.48x
P/B Ratio	4.52x
ROE	14.13%
ROCE	15.74%
EPS	Rs 24.28
Book Value Per Share	Rs 179.7
Dividend Yield	0.22%

Granules India Ltd. (GRANULES) fundamental metrics show P/E 33.48x, P/B 4.52x, ROE 14.13%, ROCE 15.74%. Taken on their own, these numbers offer context rather than a trading signal.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	33.48x
Benchmark Median P/E	31.08x
Benchmark Average P/E	46.65x
Benchmark P/E Range	3.33x to 640x
Company P/B Ratio	4.52x
Benchmark Median P/B	2.87x
Company ROE	14.13%
Benchmark Median ROE	11.48%
Company ROCE	15.74%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 22,039.25 crore
Benchmark Median Market Cap	Rs 806.56 crore

Granules India Ltd. (GRANULES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Granules India Ltd. (GRANULES) has a P/E ratio of 33.48x, which is above the benchmark median of 31.08x, a difference of +7.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.48%, a difference of +23.08%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.28%, a difference of +18.52%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,19,619.69	34.92	4.88	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,39,714.15	82.05	13.59	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,74,740.99	80.33	19.52	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,119.43	25.21	4.22	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,10,007.57	99.82	19.35	18.31	18.2

Granules India Ltd. (GRANULES) has a P/E ratio of 33.48x compared with the displayed peer median of 80.33x. The comparison is relative and should not be read as a recommendation. Its ROE of 14.13% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 22,039.25 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Granules India

• Granules India Ltd. Share Price Rise Streak is now in a second straight session, with the latest price at Rs 831.55 and a 2.92% cumulative move from Rs 807.95.
• Granules India Ltd. Share Price Today is near the top of the intraday range, which helps define the session without relying on a company-specific reason.
• Granules India Ltd. Fundamental Analysis shows P/E at 33.48, P/B at 4.52, ROE at 14.13%, ROCE at 15.74% and EPS at 24.28.
• Granules India Ltd. Share Price Rise Streak sits above the industry median on P/E, ROE and ROCE, which gives the run a valuation context within Healthcare.
• Granules India Ltd. Stock Performance can be tracked against peers such as Sun Pharmaceutical, Zydus Lifesciences, Cipla and Dr. Reddy’s Laboratories.

About Granules India

Granules India Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. For Granules India Ltd. Share Price Rise Streak readers, the key business context is simple: this is a healthcare company whose valuation is being judged alongside larger listed pharma names and other specialty peers. The current market capitalisation of Rs 22,039.25 Cr and the displayed ratios help place Granules India Ltd. Share Price Today in context.

Granules India Ltd. Stock News and Granules India Ltd. Company News interest usually centres on how the company’s business position compares with peers on price and return metrics. That is why Granules India Ltd. Share Price Rise Streak matters: it is not only a price event, but also a prompt to read the company against the industry benchmark, listed peers and its own per-share fundamentals. Univest data keeps that comparison anchored in the same set of figures.

Frequently Asked Questions

What is Granules India Ltd. Share Price today?

Ans. Granules India Ltd. Share Price is Rs 831.55 at the latest trade, up 2.29% from the previous close of Rs 812.95. The stock is also in its second straight session, which makes the move more relevant than a one-off rise.

Why is Granules India Ltd. rising today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Granules India Ltd. Share Price Rise Streak is therefore being read as a verified price pattern, not as a move with a stated trigger.

What is Granules India Ltd. market capitalisation?

Ans. Granules India Ltd. market capitalisation stands at Rs 22,039.25 Cr. In Granules India Ltd. Share Price Rise Streak terms, that size helps frame the stock against the industry median and the larger listed healthcare names in the peer set.

How does Granules India Ltd. compare on valuation?

Ans. Granules India Ltd. Share Price Today corresponds to a P/E of 33.48 and a P/B of 4.52. Both sit above the same-industry medians of 31.08 and 2.87, so the valuation is above the central benchmark level.

What do ROE and ROCE show for Granules India Ltd.?

Ans. Granules India Ltd. reports ROE of 14.13% and ROCE of 15.74%. Both are above the industry medians of 11.48% and 13.28%, which gives Granules India Ltd. Share Price Rise Streak a stronger return-ratio context.

How does Granules India Ltd. compare with peers?

Ans. Against peers such as Sun Pharmaceutical, Zydus Lifesciences, Cipla and Dr. Reddy’s Laboratories, Granules India Ltd. Share Price sits in the middle on P/E and ROE. Its market cap is also below the largest peer names shown.

What are the key fundamentals to watch for Granules India Ltd.?

Ans. The main figures are EPS of 24.28, book value of Rs 179.7 and dividend yield of 0.22%. For Granules India Ltd. Share Price Rise Streak, these per-share metrics help explain the valuation base behind the latest move.

Track Granules India Ltd. Share Price on Univest

Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Granules India Ltd. Share Price on Univest to follow the latest traded price, market capitalisation, valuation ratios, 52-week levels and other market insights in one place. Granules India Ltd. Share Price Rise Streak can be monitored alongside Granules India Ltd. Fundamental Analysis, Granules India Ltd. Stock Analysis and peer comparisons whenever the price updates.